Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26) (Q33260758)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26) |
scientific article |
Statements
1 reference
Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26) (English)
1 reference
Monika Warmuth-Metz
1 reference
Michael Flentje
1 reference
Dirk Vordermark
1 reference
Klemens Ruprecht
1 reference
Peter Rieckmann
1 reference
Wolfgang Roggendorf
1 reference
Oliver Kölbl
1 reference
18 October 2006
1 reference
1 reference
247
1 reference
18 October 2006
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference